Eusol Biotech Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was TWD 18.17 million compared to TWD 36.15 million a year ago. Basic loss per share from continuing operations was TWD 0.13 compared to TWD 0.26 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.11 TWD | 0.00% | -4.48% | -14.27% |
04-17 | Eusol Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Eusol Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-14.27% | 34.34M | |
+31.37% | 588B | |
-2.86% | 364B | |
+20.39% | 326B | |
+5.33% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.84% | 167B | |
+0.19% | 161B |
- Stock Market
- Equities
- 6652 Stock
- News Eusol Biotech Co.,Ltd.
- Eusol Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023